AIM ImmunoTech, Inc. (AIM)
1.47
-0.05
(-3.29%)
USD |
NYAM |
Dec 09, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
AIM ImmunoTech Profit Margin (Quarterly): -12.63K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -12.43K% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Electromed, Inc. | 12.65% |
| Xtant Medical Holdings, Inc. | 3.93% |
| Armata Pharmaceuticals, Inc. | -2.30K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -97.29% |
| Gross Profit Margin (Quarterly) | -369.2% |
| Operating Margin (Quarterly) | -9.10K% |
| Return on Net Operating Assets | -530.3% |